Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Rangering i aksjer #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Aksjekurs
$0.00162013
Sist synkronisert: 2025-01-03
Markedsverdi
$156.25K
Endring (1 dag)
0.36%
Endring (1 år)
0.00%
Land
SE
Handel Cyxone AB (publ) (CYXO)

Kategori

Historikk for aksjesplitt for Cyxone AB (publ) (CYXO)
Aksjen Cyxone AB (publ) (symbol: CYXO) har gjennomgått totalt 2 aksjesplitt.
Den nyeste splittelsen skjedde Dec 28, 2021.
Én CYXO-aksje kjøpt før Oct 03, 2018 tilsvarer i dag 1.12682 CYXO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2021-12-28 103:100 x1.03 x1.12682
2018-10-03 547:500 x1.094 x1.094
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE